A 16-year-old girl with thyrotoxicosis, treated successfully for two years with propylthiouracil, developed a purpuric rash, prolonged pro- thrombin time, increased split fibrin products, elevated antinuclear anti body titer and glomerular changes. The symptoms abated after ther apy with heparin and prednisone, although the ANA titer remained elevated. This is presented as the first reported instance of dissem inated intravascular clotting resulting from propylthiouracil therapy.
Get full access to this article
View all access options for this article.
References
1.
Amrhein, J.A. , Kenny, F.J. and Ross, D.: Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy. J. Pediat.76: 54, 1970.
2.
Ferreira, H.C. and Murat, L.G.: An immunological method for demonstrating fibrin degradation products in serum and its use in the diagnosis of fibrinolytic states. Brit. J. Haemat.9: 299, 1963.
3.
Hijmans, W., Doniach, D., Roitt, I.M. and Holborow, E.J.: Serologic overlap between lupus erythematosus, rheumatoid arthritis, and thyroid auto-immune diseases. Brit. Med. J.2: 909, 1961.
4.
Buchanan, W.W. , Crooks, J., Alexander , W.D., Koutras, D.A., Wayne, E.J. and Gray, K.G.: Association of Hashimoto's thymiditis and rheumatoid arthritis. Lancet1: 245, 1961.
5.
Gardner, L.I. : Endocrine and Genetic Diseases of Childhood . Philadelphia, W. B. Saunders Co. , 1969, p. 281.
6.
Messkey, C., Johnson, A.J., Kleiner, C.S. and Wohl, H.: the defibtination syndrome: clinical features and laboratory diagndsis . Brit. J. Haemat.13: 528, 1967.
7.
Hathaway, W.E. : Care of the critically ill child: the problem of disseminated intravascular coagulation. Pediatrics46: 767, 1970.
8.
Williams, R.H. : Textbook of Ehdocrwology. Philadelphia, W. B. Saunders Co., 1968, pp. 179 and 208.
9.
Best, M.M. and Duncan, C.H.: A lupus-like syndrome following propylthiouracil administration. J. Kentucky Med. Assoc.62: 47, 1964.
